fashion -WSS

fashion

author：explore 2025-08-27 16:47:28 - browse：516

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Obamacare plans could cover weight loss drugs

WSS

Cybersecurity threat forces Lurie Children's to take systems offline

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Measles policy set amid Florida outbreak alarms vaccine proponents

Medicare drug price negotiation’s day in court

Do digital therapeutics have a future in medicine?

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

knowledge

fashion

Sign up for D.C. Diagnosis

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Virginia high school admissions case could be legal follow

Medicare drug price negotiation’s day in court

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Medical leaders decry Supreme Court decision on affirmative action

Congressmen charge Covid hearing ‘could have been an email’

focus

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Some dementia cases could be undiagnosed liver disease

Biden administration opens offers in Medicare drug price negotiations

SAMSHA loosens regulations on methadone treatment centers

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Quicker fix for pulse oximeters urged during FDA public meeting

focus

hotspot

entertainment

knowledge